Regenerative Approach for SI Joint Inflammation
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Stem cells offer hope for recovery and symptom management in SI joint inflammation. Experience advanced regenerative treatment with umbilical cord-derived mesenchymal stem cells.
Can stem cell therapy help sacroiliac joint pain?
Mesenchymal stem cell therapy is not an approved treatment for sacroiliac (SI) joint dysfunction. Direct controlled evidence for MSC injection into the SI joint is very limited. Established management — physiotherapy, pelvic-belt and biomechanical assessment, image-guided steroid injection for confirmed SI-joint pain, and, in refractory cases, radiofrequency ablation or fusion — remains the evidence-based path.
Key facts
- Approval status
- Not approved for SI joint dysfunction
- Evidence
- Very limited; no controlled efficacy signal in SI joint
- Standard care
- PT, image-guided steroid injection, RFA or fusion where indicated
What we know
- Image-guided steroid injection into a confirmed SI joint can provide diagnostic and therapeutic information.
What remains uncertain
- Whether MSC injection to the SI joint offers benefit beyond established injection therapy.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Sacroiliac joint pain
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Limited
- Randomised trials?
- None identified
- Main outcomes studied
- Pain
- Function
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Sacroiliac joint pain — PubMed
- Randomised controlled trials — Sacroiliac joint pain — PubMed
- Registered MSC trials — Sacroiliac joint pain — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is SI Joint Inflammation?
Inflammation of the SI joint, where the sacrum meets the pelvis, is a condition that can lead to significant pain and discomfort, affecting individuals of all ages. This inflammation can arise from various factors, including excessive pressure, injury, or wear and tear.
At our clinic, we offer an innovative regenerative medicine application specifically designed for SI joint inflammation. this approach utilizes allogeneic mesenchymal stem cells (MSCs) derived from umbilical cord tissue, which are known for their remarkable regenerative properties.
By directly administering these powerful stem cells into the affected joint, we aim to enhance the healing process, reduce inflammation, and restore optimal joint function.
Transformative Potential
Advanced MSC Therapy
The application of umbilical cord-derived MSCs not only promotes recovery of the inflamed SI joint but also improves overall joint health, leading to increased mobility and significantly enhanced quality of life.
Why Choose Regenerative Approach for SI Joint Inflammation?
By utilizing the regenerative capabilities of umbilical cord-derived MSCs, this innovative therapy addresses underlying issues and reduces the need for surgery.
Reduced Inflammation
MSCs derived from umbilical cord tissue provide powerful anti-inflammatory effects to calm joint inflammation.
Tissue Regeneration
Stem cells promote the regeneration of damaged joint tissue and restore optimal function.
Improved Mobility
Experience increased mobility and return to daily activities with greater ease.
Enhanced Quality of Life
Patients often experience significant pain reduction leading to better overall wellbeing.
How Stem Cells Work for SI Joint Dysfunction
Mesenchymal regenerative medicine approach for sacroiliac (SI) joint dysfunction targets the damaged ligaments, inflamed joint surfaces, and destabilized structures that cause chronic pelvic and lower back pain. Clinical studies suggest MSCs can strengthen SI joint ligaments, reduce inflammation, and restore joint stability.
MSCs promote the regeneration of the sacroiliac ligaments, including the interosseous and posterior sacroiliac ligaments, by stimulating fibroblast activity and organized collagen production. This ligament strengthening helps restore the structural stability of the SI joint complex.
Stem cells deliver targeted anti-inflammatory effects to the SI joint by secreting cytokines that suppress the chronic inflammatory cascade within the joint capsule. Clinical studies suggest this reduces the pain and swelling associated with sacroiliitis and SI joint arthropathy.
MSC therapy stimulates the repair of the fibrocartilaginous surfaces of the SI joint, promoting chondrocyte activity and matrix production. This cartilage restoration improves the joint's load-bearing capacity and reduces pain during weight transfer activities.
Research indicates that MSCs modulate the nociceptive pathways around the SI joint, reducing the sensitization of local nerve endings that contributes to chronic pelvic pain. This neuromodulatory effect provides pain relief that complements the structural repairs.
Who Is a Good Candidate?
Candidacy for regenerative medicine approach in SI joint dysfunction is determined through specialized physical examination, diagnostic imaging, and often confirmatory SI joint injections. Our specialists evaluate the degree of joint instability and inflammation to design optimal care plans.
Ideal Candidates
- Patients with confirmed SI joint dysfunction as a primary source of lower back or pelvic pain
- Individuals who have experienced temporary relief from diagnostic SI joint injections, confirming the pain source
- Patients with SI joint ligament laxity or hypermobility contributing to chronic instability
- Those with sacroiliitis or early degenerative changes in the SI joint on imaging
- Patients seeking non-surgical alternatives to SI joint fusion procedures
May Not Be Suitable
- Patients with SI joint pain caused by active inflammatory spondyloarthropathy requiring systemic treatment
- Individuals with sacral fractures or significant structural deformity
- Patients with active infections in the pelvic region
- Those whose pain is primarily from lumbar spine pathology rather than the SI joint
What Results Can You Expect?
Recovery from regenerative medicine approach for SI joint dysfunction varies based on the degree of ligament laxity, joint inflammation, and individual healing capacity. The gradual strengthening of SI joint structures leads to progressive improvement over several months.
Initial Recovery
Mild soreness at the injection site and temporary increase in pelvic discomfort. Activity modification with avoidance of heavy lifting and high-impact activities is recommended.
Early Improvements
Gradual reduction in SI joint pain, particularly during transitions such as standing from sitting, walking, and climbing stairs. Anti-inflammatory effects help reduce morning stiffness.
Progressive Results
Continued improvement in pelvic stability and pain reduction. Patients report enhanced ability to tolerate prolonged standing, walking, and driving with less discomfort.
Optimal Results
Significant improvement in SI joint stability and function. Most patients experience substantial pain relief and can return to normal physical activities with greater confidence.
Long-Term Benefits
Sustained joint stability and pain relief as ligament strengthening continues. Core stabilization exercises and proper body mechanics help maintain long-term results and prevent recurrence.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
How our approach Works
All our regenerative medicine applications are evaluated and administered by specialists trained in the United States and Turkey - not general practitioners. We ensure the highest level of precision, understanding, and quality for every patient.
Step 01: Specialist Assessment
Our specialist reviews your age, previous treatments, and specific diagnostic tests to evaluate your case.
Step 02: Free Phone Consultation
Once approved, we present treatment options and pricing with a complimentary consultation to address questions.
Step 03: Stem Cell Preparation
After deposit, we prepare umbilical cord-derived mesenchymal stem cells, typically taking 5-10 days.
Step 04: Treatment Day
Free transportation to our Istanbul clinic where the specialist administers your approach and returns you safely.
Step 05: Follow-Up Care
Our follow-up specialist contacts you according to schedule to ensure maximum treatment benefits.
Expert Care
Our Expert Doctors
Under the leadership of our expert doctors, leading specialists in regenerative medicine approach, we provide specialized treatments tailored to your unique needs.
With extensive experience and a wide range of MSCs derived from umbilical cord tissue, we offer a comprehensive approach to treating SI joint inflammation. Our friendly and professional team ensures you have an enjoyable stay while receiving the best possible care.
What's Included
- Ground transportation from clinic and back
- Treatment by a certified specialist
- Certified allogeneic stem cells (97% viability)
- Personal case manager
- Follow-up aftercare
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My orthopaedic surgeon in Munich said I'd need a new knee within a year. After regenerative medicine in Istanbul, that was two years ago and I still don't need it."
"I spent years managing pain instead of living. The treatment in Turkey gave me my active life back — something I didn't think was possible at my age."
Frequently Asked Questions
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Spinal Cord Injury Rehabilitation with Stem Cells
Learn about advanced regenerative medicine applications that are supporting patients with spinal cord injuries in regaining sensation and mobility through physician-directed protocols.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleComplete Guide to Stem Cells and Their Types
Explore the different types of stem cells - adult, fetal, embryonic, and cord blood - their unique characteristics, therapeutic applications, and how they're advancing regenerative medicine.
Read ArticleHow Much Does This Cost Worldwide?
Compare this regenerative medicine costs at StemCell Longevita versus clinics in other countries.
| Country | Typical Cost |
|---|---|
| United States | $15,000 – $25,000 |
| United Kingdom | £12,000 – £20,000 |
| Germany | €15,000 – €25,000 |
| South Korea | $12,000 – $20,000 |
| StemCell Longevita (Turkey) | From £5,900 |
Prices based on market research of comparable stem cell clinics offering umbilical cord-derived MSC treatments (2025-2026). Actual prices vary by clinic, cell count, and condition.
Related clinical questions
Where this page sits in the wider picture.